Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 7, 2007, Pages 3056-3061

  Suh, Leejee H ^a   Zhang, Cheng ^a   Chuck, Roy S ^a   Stark, Walter J ^a   Naylor, Stuart ^c   Binley, Katie ^c   Chakravarti, Shukti ^a,b   Jun, Albert S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 8; GREEN FLUORESCENT PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL JUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CORNEA CELL; CRYOPRESERVATION; DNA MODIFICATION; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; ADULT; CORNEA ENDOTHELIUM; CYTOLOGY; DONOR; EQUINE INFECTIOUS ANEMIA VIRUS; FLOW CYTOMETRY; GENE EXPRESSION; GENE VECTOR; GENETICS; METABOLISM; ORGAN PRESERVATION; PHYSIOLOGY; PRESCHOOL CHILD;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; CHILD, PRESCHOOL; COLLAGEN TYPE VIII; CRYOPRESERVATION; ENDOTHELIUM, CORNEAL; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INFECTIOUS ANEMIA VIRUS, EQUINE; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; ORGAN PRESERVATION; PHOSPHOPROTEINS; TISSUE DONORS;

EID: 34548064094     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0771     Document Type: Article

References (38)

1. Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retinal Eye Res. 2003;22:359-389.
2. Joyce NC. Cell cycle status in human corneal endothelium. Exp Eye Res. 2005;81:629-638.
3. Joyce NC, Meklir B, Joyce SJ, Zieske JD. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci. 1996;37:645-655.
4. Joyce NC, Navon SE, Roy S, Zieske JD. Expression of cell cycle associated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci. 1996;37:1566-1575.
5. Baum JL, Niedra R, Davis C, Yue BY. Mass culture of human corneal endothelial cells. Arch Ophthalmol. 1984;97:1136-1140.
6. Zhu C, Joyce NC. Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci. 2004; 45:1743-1751.
7. Chen KH, Azar D, Joyce NC. Transplantation of adult human corneal endothelium ex vivo. Cornea. 2001;20:731-737.
8. Bednarz J, Teifel M, Friedl P, Engelmann K. Immortalization of human endothelial cells vising electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells. Acta Ophthalmol Scand. 2000;78:130-136.
9. Ishino Y, Sano Y, Nakamura T, et al. Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci. 2004;45:800-806.
10. Mimura T, Yamagami S, Yokoo S, et al. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci. 2004;45:2992-2997.
11. Mimura T, Amano S, Usui T, et al. Transplantation of corneas reconstructed with cultured adult human corneal endothelial cells in nude rats. Exp Eye Res. 2004;79:231-237.
12. Halberstadt M, Bohnke M, Athmann S, Hagenah M. Cryopreservation of human donor corneas with dextran. Invest Ophthalmol Vis Sci. 2003;44:5110-5115.
13. Routledge C, Armitage WJ. Ciyopreservation of cornea: a low cooling rate improves functional survival of endothelium after freezing and thawing. Cryobiology. 2003;46:277-283.
14. Brunette I, Le Francois M, Tremblay M, Guertin MC. Corneal transplant tolerance of ciyopreservation. Cornea. 2001;20:590-596.
15. Benya PD, Padilla SR. Isolation and characterization of type VIII collagen synthesized by cultured rabbit corneal endothelial cells: a conventional structure replaces the interrupted-helix model. J Biol Chem. 1986;261:4160-4169.
16. Tamura K, Konomi H, Sawada H, Takashima S, Nakajima A. Tissue distribution of type VIII collagen in human adult and fetal eyes. Invest Ophthalmol Vis Sci. 1991;32:2636-2644.
17. Sawada H, Konomi H, Hirosawa K. Characterization of the collagen in the hexagonal lattice of Descemet's membrane: its relation to type VIII collagen. J Cell Biol. 1990;110:219-227.
18. Greenhill NS, Ruger BM, Hasan Q, Davis PF. The alpha1 (VIII) and alpha2 (VIII) collagen chains form two distinct homotrimeric proteins in vivo. Matrix Biol. 2000;19:19-28.
19. Gottsch JD, Zhang C, Sundin OH, Bell WR, Stark WJ, Green WR. Fuchs corneal dystrophy: aberrant collagen distribution in an L450W mutant of the COL8A2 gene. Invest Ophthalmol Vis Sci. 2005;46:4504-4511.
20. Leung EW, Rife L, Smith RE, Kay EP. Extracellular matrix components in retrocorneal fibrous membrane in comparison to corneal endothelium and Descemet's membrane. Mol Vis. 2000;6:15-23.
21. Biswas S, Munier FL, Yardley J, et al. Missense mutations in COL8A2, the gene encoding the α2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001;10:2415-2423.
22. Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of Fuchs corneal dystrophy. Invest Ophthalmol Vis Sci. 2005;46:1934-1939.
23. Mandell KJ, Holley GP, Parkos CA, Edelhauser HF. Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci. 2006;47:2408-2416.
24. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;5259:263-267.
25. Bainbridge JWB, Stephens C, Parsley K, et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 2001;8:1665-1668.
26. Beutelspacher SC, Ardjomand N, Tan PH, et al. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res. 2005;80:787-794.
27. Maeno A, Naor J, Lee HM, et al. Three decades of corneal transplantation: indications and patient characteristics. Cornea. 2000;19:7-11.
28. Armitage WJ, Dick AD, Bourne WM. Predicting endothelial cell loss and long-term corneal graft survival. Invest Ophthalmol Vis Sci. 2003;44:3326-3331.
29. Bourne WM. Cellular changes in transplanted human corneas. Cornea. 2001;20:560-569.
30. Kikuchi M, Harris DL, Obara Y, Senoo T, Joyce NC. P27kip1 antisense-induced proliferative activity of rat corneal endothelial cells. Invest Ophthalmol Vis Sci. 2004;45:1763-1770.
31. Joyce NC, Harris DL, McAlister JC, Ali RR, Larkin DF. Effect of overexpressing the transcription factor E2F2 on cell cycle progression in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci. 2004;45:1340-1348.
32. McAlister JC, Joyce NC, Harris DL, Ali RR, Larkin DFP. Induction of replication in human corneal endothelial cells by EF2 transcription factor cDNA transfer. Invest Ophthalmol Vis Sci. 2005;46:3597-3603.
33. Beutelspacher SC, Tan PH, McClure MO, Larkin DF, Lechler RI, George AJ. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for control of alloresponses. Am J Transplant. 2006;6:1320-1330.
34. Beutelspacher SC, Pillai R, Watson MP, et al. Function of indolamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol. 2006;36:690-700.
35. Azzouz M, Ralph S, Wong LF, et al. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector. Neuroreport. 2004;15:985-990.
36. Mazarakis JD, Azzouz M, Rohll JB, et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet. 2001;10:2109-2121.
37. O'Rourke JP, Hiraragi H, Urban K, et al. Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors. Mol Ther. 2003;7:632-639.
38. Balaggan KS, Binley K, Esapa M, et al. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors. J Gene Med. 2006;8:275-285.